| NCI | National Cancer Institute |
| EMT | Epithelial to mesenchymal transition |
| PGCCs | Polyploid giant cancer cells |
| SIPS | Stress-induced premature senescence |
| CDK | Cyclin-dependent kinase |
| ATM | Ataxia telangiectasia mutated |
| SASP | Senescence-associated secretory phenotype |
| BRAF | Serine/threonine-protein kinase B-Raf |
| EGFR | epidermal growth factor receptor |
| MMR | Mismatch-repair |
| MOMP | Mitochondrial outer membrane permeabilization |
| APAF-1 | Apoptosis-activating factor-1 |
| DNase | Deoxyribonuclease |
| PS | Phosphatidylserine |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick end labeling |
| NF-κB | Nuclear factor kappa B |
| STAT3 | Signal transducer and activator of transcription 3 |
| DFNA5 | Deafness, autosomal dominant 5 |
| CRM1 | Chromosomal region maintenance 1 |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide |
| IC50 | Half-maximum inhibitory concentration |
| XTT | 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilid |
| WST-1 | Water-soluble tetrazolium salt-1 |